1H-imidazo[4,5-C]quinolin-4-amines as vaccine adjuvants

Details 1H-imidazo[4,5-C]quinolin-4-amines as vaccine adjuvants 1H-imidazo[4,5-C]quinolin-4-amines as vaccine adjuvants

1994-03-24

2000-07-04

MacMillan, Keith D.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Conjugate or complex

4242781, 4242041, 4242311, 4242361, 424 931, 42419611, 546 26, 546 79, 546 81, 546 84, 548100, 548125, 548126, A61K 39385, A61K 4500

Patent

active

060835052

ABSTRACT:
An immunogen/vaccine adjuvant composition containing an immunogen in an amount effective to stimulate an immune response and as a vaccine adjuvant a 1H-imidazo[4,5-c]quinolin-4-amine in an amount effective to increase the immune response to the immunogen.

REFERENCES:
patent: 4619827 (1986-10-01), Bull et al.
patent: 4689224 (1987-08-01), Bull et al.
patent: 4689338 (1987-08-01), Gerster
patent: 4716168 (1987-12-01), Alaimo et al.
patent: 4806352 (1989-02-01), Cantrell
patent: 4929624 (1990-05-01), Gerster et al.
patent: 5015476 (1991-05-01), Cochrum et al.
patent: 5026543 (1991-06-01), Rijke
patent: 5026546 (1991-06-01), Hilgers et al.
patent: 5037986 (1991-08-01), Gerster
patent: 5149529 (1992-09-01), Ho et al.
patent: 5268376 (1993-12-01), Gerster
patent: 5346905 (1994-09-01), Gerster
patent: 5389640 (1995-02-01), Gerster et al.
Warren et al "Current Status of Immunological Adjuvants", Ann. Rev. Immunol., 1986, 4, pp. 369-388.
J. Immunol., 1975, 115, 575-578 (Smith et al.).
Infection and Immunity , 1978, 22, 62-68 (Langford et al.).
J. Infectious Diseases, 1986, 153, (Poindexter et al.) 772-778.
Immunology, 1986, 58, 203 (Micusan et al.).
J. Clin. Invest., 1984, 73, 1312 (Ikejima et al.).
Chen, M., Griffith, B.P., Lucia, H.L. and Hsiung, G.D., "Efficacy of S-26308 Against Guinea Pig Cytomegalovirus Infection", Antimicrobial Agents and Chemotherapy, 32, (5), 678-683, 1988.
Harrison, C.J., Jenski, L., Voychehovski, T., and Bernstein, D.I., "Modification of Immunological Responses and Clinical Disease During Topical R-837 Treatment of Genital HSV-2 Infection", Antiviral Research (10), 209-224, 1988.
Kende, M., Lupton, H.W., and Canonico, P.G., "Treatment of Experimental Viral Infections with Immunomodulators", Advances in the Biosciences (68), 51-63, 1988.
S-26308. Drugs of the Future 14, (9), 870-871, 1989.
Bernstein, D.I., Harrison, C.J., "Effects of the Immunomodulating Agent R-837 on Acute and Latent Herpes Simplex Virus Type 2 Infections", Antimicrobial Agents and Chemotherapy 33, (9), 1511-1515, 1989.
S-26308. Drug of the Future (15), No. 9, 967-968, 1990.
Harrison, C.J., Stanberry, L.R., and Bernstein, D.I., "Effects of Cytokines and R-837, a Cytokine Inducer, on UV-Irradiation Augmented Recurrent Genital Herpes in Guinea Pigs", Antiviral Research (15), 315-322, 1991.
Edelman et al (1990) "Adjuvants" Intern. Rev. Immunol. 7:51-66.
Allison et al (1992) "Immunological Adjuvants and Their Mode of Action" in Vaccines: New Approaches to Immunological Problems ed by R. W. Ellis, Butterworth-Heinemann, MA pp. 431-449.
Mechanisms of Interferon Actions vol. II ed. L. M. Pfeffer CRC Press, Inc Boca Raton, Fl Chapter 12 "Interferon-Mediated Modulation of the Immune System" by H.M. Johnson pp. 59-77.
Playfair et al (1987) Clin. Exp. Immunol 67:5-10.
Grob et al (1984) Eur J. Clin. Microbiol 3(3):195-198.
Heath et al (1989) Immunology 67:520-524.

Affiliated with

Also associated with

Rating

1H-imidazo[4,5-C]quinolin-4-amines as vaccine adjuvants does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1H-imidazo[4,5-C]quinolin-4-amines as vaccine adjuvants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1H-imidazo[4,5-C]quinolin-4-amines as vaccine adjuvants will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1483511